Intra-Cellular Therapies CEO to Present at Major Conferences
![Intra-Cellular Therapies CEO to Present at Major Conferences](https://investorshangout.com/images/blog/ihnews-Intra-Cellular%20Therapies%20CEO%20to%20Present%20at%20Major%20Conferences.jpg)
Intra-Cellular Therapies to Participate in Investor Conferences
Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company known for its commitment to developing and commercializing therapeutics for central nervous system (CNS) disorders, is preparing to present at three significant investor conferences. This marks an important opportunity for shareholders and potential investors to learn more about the company's groundbreaking work in the biopharmaceutical field.
Conference Details
Sharon Mates, Ph.D., the Chief Executive Officer and Chairman of Intra-Cellular Therapies, will lead presentations at the following conferences:
Morgan Stanley 22nd Annual Global Healthcare Conference
The first conference, the Morgan Stanley 22nd Annual Global Healthcare Conference, is scheduled for September 4. Dr. Mates will address attendees at 10:00 a.m. ET, providing insights into the company’s latest developments and future directions.
Baird’s 2024 Global Healthcare Conference
The second event on the calendar is Baird’s 2024 Global Healthcare Conference, taking place on September 11 at 11:25 a.m. ET. This conference promises to enrich the discourse surrounding innovative healthcare solutions and pharmaceutical advancements.
2024 Cantor Global Healthcare Conference
The final conference participation will be at the 2024 Cantor Global Healthcare Conference, where Dr. Mates is set to present on September 18 at 10:55 a.m. ET. Each presentation provides a platform to delve into Intra-Cellular Therapies’ commitment to mental health and neurological progress.
Accessing the Presentations
For those unable to attend in person, a live and archived webcast of the presentations will be made available. Interested individuals can find more details under the 'Events & Presentations' section in the Investors area on the company's official website. It's recommended to log in approximately 5-10 minutes before the event to ensure smooth registration and to manage any software installations required for viewing.
Company Overview
Intra-Cellular Therapies operates at the forefront of neurological research, harnessing Nobel prize-winning science to uncover the cellular mechanisms that underpin neurological and psychiatric conditions. The company is dedicated to advancing treatments for complex psychiatric and neurologic diseases, positioning itself as a pioneer in the biopharmaceutical sector. Its innovative intracellular approach is integral to developing therapeutics that aim to improve the quality of life for those affected.
Contact Information
For further inquiries or information regarding presentations or the company’s strategies, interested parties can reach out to:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333
For media inquiries, contact Burns McClellan, Inc.
Cameron Radinovic
646-930-4406
Frequently Asked Questions
What is Intra-Cellular Therapies known for?
Intra-Cellular Therapies is known for developing innovative therapeutics for central nervous system disorders.
Who will be presenting at the upcoming conferences?
Dr. Sharon Mates, the CEO and Chairman of Intra-Cellular Therapies, will be presenting.
When are the upcoming investor conferences?
The conferences are scheduled for September 4, September 11, and September 18.
How can the presentations be accessed?
The presentations can be accessed via a live and archived webcast on the company's official website in the Investors section.
What is the focus of Intra-Cellular Therapies?
The focus of Intra-Cellular Therapies is on developing treatments for psychiatric and neurologic diseases based on a cellular understanding of the body.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Coiled Tubing Market to Reach $6.5 Billion Driven by Innovation
- Challenges and Advances in Sickle Cell Disease Treatments
- FFW Corporation Declares $0.30 Quarterly Dividend
- NewtekOne, Inc. CEO Barry Sloane to Attend Key Conference
- AUGA group, AB Investor Conference Webinar Details
- Public Opening Position Disclosure by Rathbones Group Plc
- Loupe Offers Exciting Rewards for Topps Chrome Basketball
- DCHFA Relaunches ReMIT Program to Assist Seniors
- RealManage Achieves 2024 Great Place to Work Certification
- Maternal Nutrition Products Market Set to Reach $38.66 Billion